Erlotinib Tablets I.p. 100 Mg
Erlotinib Tablets I.p. 100 Mg

Erlotinib Tablets I.p. 100 Mg

MOQ : 10 Pieces

Erlotinib Tablets I.p. 100 Mg Specification

  • Dosage Form
  • Tablet
  • Indication
  • Non-small cell lung cancer, pancreatic cancer, other types of cancer as prescribed
  • Salt Composition
  • Erlotinib 100 mg
  • Feature
  • Prescription drug, anticancer, oral tablet
  • Ingredients
  • Erlotinib Hydrochloride and excipients
  • Application
  • Oral anticancer therapy
  • Physical Color/Texture
  • Tablet form, white to off-white
  • Storage Instructions
  • Store below 30C, protect from light and moisture
  • Shelf Life
  • 24 months
  • Prescription/Non Prescription
  • Prescription
  • Brand Name
  • ERLOTERO-100
  • Packaging Type
  • Box
  • Caution
  • To be sold by retail on the prescription of an oncologist only
  • Marketed By
  • Mylan Pharmaceuticals
  • Usage
  • As directed by oncologist
  • Patient Category
  • Adults
  • Route of Administration
  • Oral
  • Side Effects
  • Rash, diarrhea, loss of appetite, fatigue
  • Pack Size
  • 30 Tablets per box
  • Regulatory Status
  • IP (Indian Pharmacopoeia)
  • Drug Class
  • Tyrosine Kinase Inhibitor
  • Strength
  • 100 mg per tablet
 
 

Erlotinib Tablets I.p. 100 Mg About



Experience imposing efficacy with ERLOTERO-100 (Erlotinib Tablets I.P. 100 mg), a lustrous choice for oral anticancer therapy. Specially formulated by Mylan Pharmaceuticals, these ace tablets are trusted for the treatment of non-small cell lung cancer, pancreatic cancer, and other conditions as prescribed. Each pack contains 30 tablets, designed for adult use under oncologist guidance. Get It Now-Pick Yours and Personalise your cancer management with confidence. ERLOTERO-100 is a prescription-only medicine, featuring superior quality, safety, and a 24-month shelf life. Store securely below 30C, away from light and moisture.

Targeted Cancer Therapy With Erlotinib Tablets I.P. 100 mg

Erlotinib Tablets I.P. 100 mg, marketed as ERLOTERO-100, are suitable for adult patients requiring targeted therapy for cancers such as non-small cell lung cancer and pancreatic cancer. This prescription medication harnesses the power of tyrosine kinase inhibition and is administered orally, ensuring patient convenience. Special features include strict adherence to Indian Pharmacopoeia standards, high pharmaceutical quality, and ease of storage, making it an ideal application for intensive cancer care as directed by an oncologist.


Comprehensive Packaging and Supply Details for Erlotinib Tablets

ERLOTERO-100 comes securely packed in boxes containing 30 tablets each, ensuring integrity and protection from moisture and light. We supply directly from India, with flexible payment terms to suit your requirements. The FOB Port is available for prompt distribution, and you may request a quotation or inquire about the asking price for bulk orders. Our responsive service ensures that all shipment and delivery arrangements for Erlotinib Tablets I.P. 100 mg align with your needs.


FAQ's of Erlotinib Tablets I.p. 100 Mg:


Q: How should ERLOTERO-100 (Erlotinib Tablets I.P. 100 mg) be taken?

A: ERLOTERO-100 tablets should be taken orally, strictly as directed by your oncologist. It is essential to follow the prescribed dosage and schedule for optimal effectiveness.

Q: What conditions are treated with Erlotinib Tablets I.P. 100 mg?

A: Erlotinib Tablets are indicated for the treatment of non-small cell lung cancer, pancreatic cancer, and may be used for other cancers upon your oncologist's recommendation.

Q: When should I consult my oncologist about starting ERLOTERO-100?

A: Consult your oncologist promptly if you have been diagnosed with cancers appropriate for Erlotinib therapy. Only they can determine if this medication is right for your condition.

Q: Where should ERLOTERO-100 be stored for best results?

A: Store ERLOTERO-100 below 30C, in a dry place protected from light and moisture, to maintain its efficacy throughout its 24-month shelf life.

Q: What are the possible side effects of using Erlotinib Tablets?

A: Common side effects include rash, diarrhea, loss of appetite, and fatigue. Speak with your oncologist about any side effects or health concerns you observe during treatment.

Q: How can I get a quotation or inquire about the supply of ERLOTERO-100?

A: You can request a quotation or supply information by contacting our distribution team directly. We offer flexible payment terms and will provide asking prices and further details upon inquiry.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology Drugs Category

Zoldonat Zoledronic Acid 4mg Injection

Zoldonat Zoledronic Acid 4mg Injection

Minimum Order Quantity : 10 Pieces

Indication : Used for the treatment of osteoporosis, hypercalcemia of malignancy, Pagets disease, and prevention of skeletalrelated events in cancer patients

Application : Other, Intravenous administration in clinical or hospital settings

Feature : Other, Single dose vial, sterile, ready for intravenous use

Shelf Life : 24 months from date of manufacture

Salt Composition : Zoledronic Acid 4mg

Gefitinib Gefticip 250mg Tablet

Gefitinib Gefticip 250mg Tablet

Minimum Order Quantity : 10 Packs

Indication : NonSmall Cell Lung Cancer (NSCLC)

Application : Other, Cancer Therapy

Feature : Other, Oral targeted therapy for cancer

Shelf Life : 24 Months

Salt Composition : Gefitinib 250mg

Pomalid Pomalidomide 4 Mg Capsules

Pomalid Pomalidomide 4 Mg Capsules

Minimum Order Quantity : 10 Pieces

Indication : Multiple Myeloma (in patients who have received at least two prior therapies)

Application : Other, Oral administration for anticancer therapy

Feature : Other, Oral anticancer medication, immune modulating agent

Shelf Life : 24 months from manufacturing date

Salt Composition : Pomalidomide

Regonat 40 Mg Regorafenib

Regonat 40 Mg Regorafenib

Minimum Order Quantity : 10 Pieces

Indication : Treatment of metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma

Application : Other, Oral administration, anticancer treatment

Feature : Other, Prescription medication, effective oral targeted therapy

Shelf Life : 24 months

Salt Composition : Regorafenib 40 mg



Back to top